Genetic Heterogeneity in Renal Cell Carcinoma: Clinical Implications?
- 1 November 2014
- book chapter
- Published by Springer Nature
- p. 167-176
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Heterogeneity and Tumor HistoryScience, 2012
- ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic DiseaseEuropean Urology, 2011
- VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIFα: Identification of Potential Driver and Passenger MutationsCancer Research, 2011
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialJournal of Clinical Oncology, 2010
- von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell CarcinomaJournal of Urology, 2008
- Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II studyThe Lancet Oncology, 2007
- Sunitinib Efficacy Against Advanced Renal Cell CarcinomaJournal of Urology, 2007
- Sunitinib malate for the treatment of solid tumours: a review of current clinical dataExpert Opinion on Investigational Drugs, 2006
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003